Keith Murphy: “We Believe We are Discovering the Next Step in Drug Development”

It’s been three years since Keith Murphy and Jeffrey Miner joined forces to create the biotechnology company Viscient Biosciences. In 2017, the co-founders had recently left their previous successful enterprises…

Organovo’s Merger Deal with Tarveda Falls Through, for Now

It has been a stormy few months for the early-stage medical laboratory and research company Organovo. Since announcing a merger deal with Tarveda Therapeutics, a privately-held clinical-stage biopharmaceutical firm, last…

Former CEO of Organovo Urges Stockholders Against Merger with Tarveda

Gaining a competitive advantage is at the core of most businesses. That is why the financial world has a section dedicated exclusively to study the behind-the-scenes of mergers and acquisitions…

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our

You have Successfully Subscribed!